rss
J Clin Pathol 2006;59:396-402 doi:10.1136/jcp.2005.029215
  • Original article

Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7

  1. H Agis1,
  2. M-T Krauth1,
  3. I Mosberger2,
  4. L Müllauer2,
  5. I Simonitsch-Klupp2,
  6. L B Schwartz3,
  7. D Printz4,
  8. A Böhm1,
  9. G Fritsch4,
  10. H-P Horny5,
  11. P Valent1
  1. 1Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Austria
  2. 2Department of Clinical Pathology, Medical University of Vienna
  3. 3Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA
  4. 4Children’s Cancer Research Institute, St Anna Children’s Hospital, Vienna, Austria
  5. 5Department of Pathology, University of Lübeck, Germany
  1. Correspondence to:
    Dr Peter Valent
    Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria; peter.valent{at}meduniwien.ac.at
  • Accepted 27 June 2005
  • Published Online First 3 February 2006

Abstract

Background: Basophils are highly specialised granulocytes that express a unique profile of antigens and increase in myeloproliferative disorders (MPD). In chronic myeloid leukaemia (CML), basophilia is a diagnostic and prognostic determinant. So far, however, no reliable approach for routine detection and enumeration of bone marrow basophils has become available.

Objective: To detect and enumerate basophils in bone marrow sections in patients with CML and other MPD

Methods: The anti-basophil antibody 2D7 was applied to paraffin embedded bone marrow sections from normal/reactive subjects (n = 31), patients with CML (chronic phase, n = 37; accelerated phase, n = 9), and other MPD (chronic idiopathic myelofibrosis (CIMF), n = 20; polycythaemia vera (PV), n = 20; essential thrombocythaemia (ET), n = 20; indolent systemic mastocytosis (ISM), n = 7).

Results: As assessed by serial section staining, 2D7+ cells were found to co-express myeloperoxidase, histidine decarboxylase, CD9, and CD43, but did not express B cell or T cell restricted antigens. 2D7+ bone marrow cells were found to increase in CML compared with normal/reactive bone marrow and other MPD (median numbers of 2D7+ cells/mm2: CML, 33; normal/reactive bone marrow, 6; CIMF, 10; PV, 6; ET, 5; ISM, 3; p<0.05). The highest basophil counts were recorded in accelerated phase CML (115/mm2).

Conclusions: A novel immunohistochemical procedure has been established for basophil detection in normal bone marrow and MPD. This approach should help in the quantification of bone marrow basophils at diagnosis and during anti-leukaemic treatment.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF
    4. All versions of this article:
      1. jcp.2005.029215v1
      2. 59/4/396 most recent

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.